Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01478
|
|||||
| Drug Name |
Quinacrine
|
|||||
| Synonyms |
quinacrine; mepacrine; atabrine; Acrinamine; Acriquine; 83-89-6; Quinactine; Antimalarina; Haffkinine; Akrichin; Italchine; acrichine; Erion; Mepacrinum; Quinacrine hydrochloride; Mepacrine [INN:BAN]; St 439; Mepacrinum [INN-Latin]; Mepacrina [INN-Spanish]; atebrin; Malaricida; Methoquine; Palacrin; Italchin; Pentilen; Palusan; Atebrine; Metochin; Mecryl; Quinacrine, Mepacrine; 3-Chloro-7-methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine; 2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine; HSDB 3253
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Prostate cancer [ICD11: 2C82] | Phase 2 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C23H30ClN3O
|
|||||
| Canonical SMILES |
CCN(CC)CCCC(C)NC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC
|
|||||
| InChI |
InChI=1S/C23H30ClN3O/c1-5-27(6-2)13-7-8-16(3)25-23-19-11-9-17(24)14-22(19)26-21-12-10-18(28-4)15-20(21)23/h9-12,14-16H,5-8,13H2,1-4H3,(H,25,26)
|
|||||
| InChIKey |
GPKJTRJOBQGKQK-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 83-89-6
|
|||||
| Pharmaceutical Properties | Molecular Weight | 400 | Topological Polar Surface Area | 37.4 | ||
| Heavy Atom Count | 28 | Rotatable Bond Count | 9 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
6
|
|||||
| PubChem CID | ||||||
| PubChem SID |
9546
, 598066
, 3138736
, 5198883
, 8150522
, 10589337
, 11335276
, 11360515
, 11363823
, 11364917
, 11366385
, 11367479
, 11368947
, 11370041
, 11371712
, 11373080
, 11374150
, 11375641
, 11377109
, 11378211
, 11405321
, 11461487
, 11466346
, 11467466
, 11484412
, 11486271
, 11488704
, 11490422
, 11492311
, 11494743
, 11533330
, 14781277
, 24262994
, 24438614
, 25820836
, 46507828
, 47365028
, 47440097
, 47736309
, 48034955
, 48034956
, 48110303
, 48110304
, 48184845
, 48334330
, 48415587
, 49698889
, 49864262
, 50111199
, 53790823
|
|||||
| ChEBI ID |
CHEBI:8711
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | BCRP | Transporter Info | Breast cancer resistance protein | Substrate | [2] | |
| References | ||||||
| 1 | ClinicalTrials.gov (NCT00417274) Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer | |||||
| 2 | Arginine-482 is not essential for transport of antibiotics, primary bile acids and unconjugated sterols by the human breast cancer resistance protein (ABCG2). Biochem J. 2005 Jan 15;385(Pt 2):419-26. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.